The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Maxolon 5 mg/ml Solution for Injection

Amdipharm LimitedPA1142/011/001

Main Information

Trade NameMaxolon 5 mg/ml Solution for Injection
Active SubstancesMetoclopramide hydrochloride
Dosage FormSolution for injection
Licence HolderAmdipharm Limited
Licence NumberPA1142/011/001

Group Information

ATC CodeA03FA Propulsives
A03FA01 metoclopramide


License statusAuthorised
Licence Issued01/04/1994
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back